During clinical trials, the US Food and DrugAdministration ( FDA) said Veklury, the brandname of the drug, reduced the recovery time byan average of five days.
“Veklury is the first treatment to obtain FDAapproval for COVID-19,” the FDA said in astatement.
Absolute approval of the antiviral drugremdesivir for the treatment of COVID-19 patients in hospitals was issued by USregulators.
The World Health Organization (WHO) saidremdesivir had little or no impact on the survivalof patients last week.
The WHO said that this was based on its owntesting, but the drug maker Gilead denied thetrial’s results.
Since May, Remdesivir has been approved foremergency use only in the US.
President Donald Trump was recently granted itafter he tested positive for COVID-19.